Browsing Artículos (Instituto de Biomedicina de Sevilla (IBIS)) by Subject "Cancer treatment"
Now showing items 1-1 of 1
-
Article
Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src.
(Impact Journals, 2016-04-20)Despite the development of new antineoplastic agents for the treatment of colorectal cancer (CRC), oxaliplatin and ...